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The role of alpha () and beta () haemolysins in blood transfusion has been well documented. 
However, the occurrence of haemolysins and its attending problems in sickle cell anaemia (SCA) 
patients has limited appearance in the literatures especially in black Africa. This study was therefore 
designed to investigate the occurrence of  and  haemolysins in SCA patients within Calabar 
metropolis. A total of 50 normal controls and 54 SCA patients attending the sickle cell clinic of the 
University of Calabar Teaching Hospital, Cross River State of Nigeria, were screened for haemolysins 
and quantitated using standard techniques. The distribution of haemolysins in the SCA patients was  
(16.7),  (11.1) and + (16.7%). Their ABO blood groups were normally distributed in this order 
O>>A>B>AB (61.1, 20.4, 11.1 and 7.5%, respectively). The occurrence of  haemolysin among the O 
group was 15.2%, while  haemolysin was 12.1% and + haemolysin was 30.3%. Control samples gave 
non-significantly lower haemolysin values than in SCA patients (P>0.05), but in the same order (, 9.0, 
, 7.0, and +, 9.0%). The higher prevalence of haemolysins in SCA could be a major limiting factor in 
donation of blood, blood selection and transfusion into SCA patients. Consequently, greater care 
should be taken during cross match of blood for SCA patients especially in multiple transfusion 
procedures. 
 





Sickle cell disorder is a group of inherited disorders of 
haemoglobin. These disorders include sickle cell anae-
mia, sickle cell haemoglobin C disease (HbSC), and sic-
kle cell thalassaemia (HbSBTHAL). Of these, sickle cell 
anaemia (SCA) is most prevalent with clinical manifesta-
tions attributed to the substitution of valine for glutamic 
acid at the sixth residue of the -chain from the N-
terminus of the sickle haemoglobin (HbS) protein chain.  
Red blood cells, which contain HbS when exposed to 
reduce oxygen tension, assume a characteristic sickle 
shape. The sickle cell phenomenon is inherited as mend- 
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homozygous state for the HbS gene (HbSS); the patient 
receiving one HbS gene from each parent, both of who 
show sickle cell trait (Bunn and Forget, 1986). 
Haemolysin is a type of antibody that has the ability of 
combining with its specific antigen on the red blood cells 
and together with complement cause destruction of 
thecells. Haemolysin can be either IgG or IgM immuno-
globulin. Hence its characteristic depends on the immu-
noglobulin class of the haemolysin antibody. It can be 
divided into alpha (), beta () and alpha plus beta (+) 
haemolysin types. Alpha haemolysin may be detected in 
ABO blood group B and O individuals, while  haemoly-
sin may be present in group A and O persons (Boorman 
et al., 1988). Immune haemolysin production may occur 
following ABO heterospecific pregnancy, incompatible 
blood transfusion or immunization with A or B substances 
(Usanga and Akwiwu, 1990).  Alpha  and    haemolysins 




Table 1. Influence of sex on development of haemolysin antibodies in the 
subjects. 
 
Subjects  (%)  (%) + (%) Nil (%) Total 
Controls 
Male 4(8.6) 3(6.5) 6(13.0) 33(71.7) 46 
Female 5(9.3) 4(7.4) 3(5.6) 42(77.7) 54 
SCA Patients 
Male 8(23.5) 4(11.8) 4(11.8) 18(52.9) 34 
Female 1(5.0) 2(10.0) 5(25.0) 12(60.0) 20 
 
Percentages were calculated per row. = Alpha haemolysin,  = beta haemo-




occur more in blood group O donors than in other blood 
group donor types put together (Emeribe, 1990). 
Haemolysin is important in blood group serology 
because of its incrimination in transfusion reactions and 
haemolytic disease of the newborn (HDN). Hence, this 
study was aimed at determining the occurrence of haem-
olysin antibodies in sickle cell anaemia patients in 
Calabar metropolis of Nigeria. These patients, because of 
the presence of HbSS are prone to intravascular haemo-
lysis and associated crisis, and thus could be in danger 








The subjects were made up of 54 SCA patients attending sickle cell 
clinic of the University of Calabar Teaching Hospital, Calabar. The 
patients were age-matched with 100 apparently healthy (non-sickle 
cell patients and non-trait carriers) control subjects from Govern-
ment School Obufa Esuk in University of Calabar, Cross River, 
Nigeria.  
Ethical approval was obtained from the hospital Ethical commi-






Five milliliters (5 ml) of venous blood was obtained from each of the 
subjects. About 1 ml of the blood was dispensed into a plain 
container, allowed to clot and retract. Serum was separated from 
the whole blood after centrifugation and stored frozen at –20oC for 
haemolysin analysis. The remaining venous blood was dispensed 





The anticoagulated blood was centrifuged, red blood cells sepa-
rated and washed three times in physiological saline. Then to 1 
volume of washed red cells, 2 volumes of Drabkins solution was 
added to lyse the cells. The lysed cells solution was mixed tho-
roughly and centrifuged at 3000 rpm for 5 min. The supernatant 
obtained was used as the haemolysate for the Hb electrophoresis. 
The Hb electrophoresis was carried out and interpreted as descry-
bed by Dacie and Lewis (Dacie and Lewis, 1994). 
 
 
ABO and Rhesus blood grouping 
 
Potent anti-A, anti-B, anti-A+B and anti-D sera were used to group 
the subjects’ red cells as described by Dacie and Lewis (1994). 
 
 
Haemolysin test and titration 
 
Known A, B and O red cells were used to test the subjects’ sera for 
agglutination and subsequent haemolysis of the red cells in the 
presence of haemolysin and complement in the fresh sera samples. 
Sera samples that showed evidence of haemolysis were selected 





Chi-square test was used for the statistical analysis of data obtai-






ABO haemolysin antibodies were detected in the sera of 
54 SCA patients consisting of 34 male and 20 female. 
The study of the influence of sex on development of 
haemolysin antibodies (Table 1) shows that male sub-
jects had a significantly higher occurrence of  (23.5%) 
and  (11.8%) amongst the SCA patients and + 
(13.0%) amongst the male controls (P<0.05), but with 
non significantly lower occurrences of + (11.8%) 
amongst the SCA patients and  (8.6%) and  (6.5%) 
amongst the control subjects (P>0.05) when compared 
with their female counterparts. However, majority of both 
sexes had no haemolysins detected in their sera. 
The effect of age on the development of haemolysin in 
SCA patients is presented in Table 2. It shows that age 
has a great influence over the production of haemolysin. 
There was a significant increase in haemolysin antibodies 
as age increased; age ranges  7 years (34.1%), 8 – 14 
years (38.9%) and 15 - 21 years (37.0%) (P<0.05). 




Table 2. Effect of age on development of haemolysin antibodies in the SCA patients. 
 
Age range (years)  (%)  (%) + (%) Nil (%) Total 
 1 – 7 0 (0.0) 1 (7.6) 0 (0.0) 12 (92.3) 13 
8 – 14 6 (28.6) 2 (9.5) 3 (14.2) 10 (47.6) 21 
15 – 21 3 (15.0) 3 (15.0) 6 (30.6) 8 (40.0) 20 
 
Percentages were calculated per row.  = Alpha haemolysin,  = beta haemolysin, + = 




Table 3. Distribution of haemolysin antibodies in the various ABO blood groups among the subjects. 
 
Blood group Subjects 
A B AB O Total 
Number of SCA patients 11 6 4 33 54 
SCA patients with haemolysin (%) 2 (8.3) 3 (12.5) 0 (0.0) 19 (79.2) 24 (44.4) 
Number of control subjects 14 11 5 70 100 




Table 4. Prevalence of haemolysin antibodies among blood group O subjects. 
 
Subjects  (%)  (%) + (%) Nil (%) Total 
Controls 
Male 3 (9.4) 3 (9.4) 6 (18.8) 20 (62.5) 32 
Female 4 (10.5) 4 (10.5) 3 (7.9) 27 (71.1) 38 
SCA patients 
Male  4 (19.0) 2 (9.5) 5 (23.8) 10 (47.6) 21 
Female 1 (8.3) 2 (16.7) 5 (41.7) 4 (33.3) 12 
 
Percentages were calculated per row.  = Alpha haemolysin,  = beta 




Table 3 presents the distribution of haemolysin in 
various ABO blood groups among the subjects. The 
results show that blood group O subjects had the highest 
occurrence of haemolysin (85.7%), followed by blood 
group B (8.2%), and then blood group A (6.1%) with 
blood group AB subjects having no detectable haemo-
lysin presence. The distribution of haemolysin amongst 
the blood group O subjects is showed in Table 4. The 
frequency of occurrence of  (19.0%) haemolysin was 
higher in male blood group O SCA patients than the 
female blood group O SCA patients. On the other hand, 
there was no significant difference in the rates of occur-
rence of the haemolysin antibodies between the male 
and female blood group O control subjects (P>0.05). 
Influence of ethnicity on development of haemolysin is 
shown in Table 5. It indicates that ethnicity has no influe-





Asian and black populations have been reported to have 
high frequency of strong haemolytic anti-A and anti-B 
haemolysins in comparison to Caucasians (Redman et 
al., 1990; Kulkarni et al., 1985; Adewuyi and Gwanzura, 
2001). The higher frequency of haemolysins in these 
populations has been attributed to mosquito bites and 
intestinal parasitic infections, as well as a con-sequence 
of vaccinations or other antigens exposures (Mathai et 
al., 2003). 
There is at present scarcity of information on SCA 
patients who are prone to crisis-associated intravascular 
haemolysis and hence may require blood and blood 
products transfusion frequently. High frequency of haem- 
olysin antibodies was observed among the SCA patients 
in this study. This may be due to environmental factors as 
discussed by Mathai and colleagues (Mathai et al., 2003), 
or a consequence of previous blood transfusions. This is 
because these patients live in a malaria endemic area 
and about 90% of them have been transfused with blood 
at least once. This could be further buttressed by the fact 
that blood group O individuals are still falsely considered 
and used as universal donors in Nigeria (Olawumi and 
Olatunji, 2001). The risk associated with this is further 
enhanced by the highly significant occurrence of  haemo- 




Table 5. Influence of ethnicity on development of haemolysin. 
 
Ethnic groups  (%)  (%) + (%) Nil (%) Total 
Controls 
Indigenes 4 (11.2) 2 (5.7) 3 (8.5) 26 (74.2) 35 
Ibibios 1 (2.5) 5 (12.5) 4 (10.0) 30 (75.0) 40 
Ibos & Yorubas 4 (16.0) 0 (0.0) 2 (8.0) 19 (76.0) 25 
SCA patients 
Indigenes 6 (19.4) 2 (6.5) 6 (19.4) 17 (54.8) 31 
Ibibios 0 (0.0) 0 (0.0) 0 (0.0) 5 (100.0) 5 
Ibos & Yorubas 3 (16.6) 4 (22.2) 3 (16.6) 8 (44.4) 18 
 
Percentages were calculated per row. = Alpha haemolysin,  = beta haemolysin, + = 
alpha plus beta haemolysin, and Nil = absence of haemolysin. The indigenes include all 




lysin antibodies in the blood group O subjects in compa-
rison with the other blood group classes. Thus, the use of 
blood group O for group A or B recipients have been 
advocated against (Emeribe, 1990). We wish to strongly 
reiterate this position given the high frequency of haemo-
lysin antibodies observed among the blood groups A, B, 
and O SCA patients.  
A study of the influence of sex, age and ethnicity on the 
frequency of haemolysin among the SCA patients 
showed no significant relationship. However, a compa-
rison of the frequency of occurrence between the patients 
and control group with respect to their sex showed 
significant increase in haemolysin among the male than 
the female. This is in disagreement with previous reports 
of higher occurrence in girls than boys (Millison, 1979), 
and no relationship between sex and the prevalence of 
haemolysin (Olawumi and Olatunji, 2001). The effect of 
age on development of haemolysin antibodies in SCA 
patients showed that as age increased, haemolysin 
frequency tends to increase as well. The study shows 
that haemolysin development rate increased most betw-
een the ages of 8 to 14 years. This observation is in 
consonance with the finding that the maximum levels of 
haemolysin are attained at about the ages of 7 to 8 years 
(Millison, 1979). However, these differ with recent report 
of no relationship between age and haemolysin occur-
rence (Olawumi and Olatunji, 2001). On the other hand, a 
study of the effect of ethnicity on haemolysin occurrence 
among the SCA patients and control subjects showed no 
significant relationship. This could be seen to differ with 
the report of Kulkarni et al (1985) which stated that high 
frequency of these haemolysins occur among ethnic 
groups originating from the southern part of Nigeria. 
However, that report collaborates our observations of 
high frequency of haemolysin among these subjects who 
coincidentally are all from the southern part of Nigeria. 
In conclusion, sickle cell anaemia patients have high 




ficantly with age and occurrence of ABO blood groups O, 
B and A. The higher prevalence of haemo-lysins in SCA 
patients could be a major limiting factor in donation of 
blood, selection of blood and transfusion into the SCA 
patients. Thus greater care should be taken during cross-
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